Dr. Emily Greengard
Claim this profileUniversity of Minnesota/Masonic Cancer Center
Expert in Head and Neck Cancers
Expert in Cancer
46 reported clinical trials
74 drugs studied
About Emily Greengard
Education:
- Earned an MD from Saint Louis University School of Medicine in 2004.
Experience:
- Completed a Residency in Pediatrics at Children's Memorial Hospital, Chicago, IL, in 2007.
- Finished a Fellowship in Pediatric Hematology-Oncology at Children's Hospital of Philadelphia in 2010.
- Served as an Instructor in Pediatrics at the University of Pennsylvania School of Medicine (2007-2010).
- Currently an Associate Professor of Pediatrics in the Division of Hematology/Oncology at the University of Minnesota and Fellowship Program Director for Pediatric Hematology/Oncology.
Area of expertise
1Head And Neck Cancers
Global LeaderStage IV
Stage I
Stage II
2Cancer
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Emily Greengard is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Emily Greengard
Clinical Trial Related4 years of experience running clinical trials · Led 46 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Emily Greengard has experience with
- Cyclophosphamide
- Ramucirumab
- Vinorelbine
- Irinotecan
- Dinutuximab
- Temozolomide
Breakdown of trials Emily Greengard has run
Head and Neck Cancers
Cancer
Neuroblastoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Greengard specialize in?
Emily Greengard focuses on Head and Neck Cancers and Cancer. In particular, much of their work with Head and Neck Cancers has involved Stage IV patients, or patients who are Stage I.
Is Emily Greengard currently recruiting for clinical trials?
Yes, Emily Greengard is currently recruiting for 15 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Emily Greengard has studied deeply?
Yes, Emily Greengard has studied treatments such as Cyclophosphamide, Ramucirumab, Vinorelbine.
What is the best way to schedule an appointment with Emily Greengard?
Apply for one of the trials that Emily Greengard is conducting.
What is the office address of Emily Greengard?
The office of Emily Greengard is located at: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota 55455 United States. This is the address for their practice at the University of Minnesota/Masonic Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.